Literature DB >> 16369121

Helicobacter pylori seroprevalence in patients with chronic obstructive pulmonary disease and its relation to pulmonary function tests.

Mehmet Gencer1, Erkan Ceylan, Fadile Yildiz Zeyrek, Nurten Aksoy.   

Abstract

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a slowly progressive condition characterized by poorly reversible airflow limitation that is associated with an abnormal inflammatory response of the lung. It has been shown that there is a seroepidemiological association of Helicobacter pylori (Hp) infection with many inflammatory conditions.
OBJECTIVE: In this study, we aimed to investigate seroprevalence in Hp patients with COPD and to determine whether there is an association between Hp infection and COPD.
METHODS: Forty-nine voluntary patients with COPD and 50 healthy control subjects of similar age and sex were included in the study. Hp-specific IgG was measured with a commercially available kit from venous blood samples.
RESULTS: Serum levels of Hp-specific IgG and Hp IgG seropositivity were significantly higher in the patients with COPD than in the control subjects (p < 0.001 and p = 0.006, respectively). In addition, when the patients with COPD were grouped according to Hp IgG seropositivity, forced expiratory volume in 1 s (FEV(1)) values were lower in the seropositive patients compared to seronegative patients, and Hp serum IgG levels were correlated with FEV(1) values, which indicate the severity of COPD, in the COPD group (r = -0.306, p = 0.032).
CONCLUSION: The results suggest that there is an association between Hp infection and COPD, and Hp IgG levels are correlated with the severity of COPD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16369121     DOI: 10.1159/000090158

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  7 in total

1.  Helicobacter pylori infections in chronic obstructive pulmonary disease.

Authors:  Ali Tabaru; Metin Gorguner; Metin Akgun; Mehmet Meral; Ali Sahin
Journal:  Eurasian J Med       Date:  2012-12

2.  Factors affecting first-line triple therapy of Helicobacter pylori including CYP2C19 genotype and antibiotic resistance.

Authors:  Ju Yup Lee; Nayoung Kim; Min Soo Kim; Yoon Jin Choi; Jung Won Lee; Hyuk Yoon; Cheol Min Shin; Young Soo Park; Dong Ho Lee; Hyun Chae Jung
Journal:  Dig Dis Sci       Date:  2014-03-06       Impact factor: 3.199

Review 3.  Can Helicobacter pylori infection influence human reproduction?

Authors:  Elena Moretti; Natale Figura; Giulia Collodel; Antonio Ponzetto
Journal:  World J Gastroenterol       Date:  2014-05-21       Impact factor: 5.742

4.  Detection of helicobacter pylori in bronchoalveolar lavage of patients with chronic obstructive pulmonary disease by real time polymerase chain reaction.

Authors:  Mitra Samareh Fekri; Seyed Mehdi Hashemi Bajgani; Atefe Rasti; Rostam Yazdani; Hamid Reza Mollaie
Journal:  Jundishapur J Microbiol       Date:  2014-12-07       Impact factor: 0.747

5.  LRLSHMDA: Laplacian Regularized Least Squares for Human Microbe-Disease Association prediction.

Authors:  Fan Wang; Zhi-An Huang; Xing Chen; Zexuan Zhu; Zhenkun Wen; Jiyun Zhao; Gui-Ying Yan
Journal:  Sci Rep       Date:  2017-08-08       Impact factor: 4.379

6.  Association between Helicobacter pylori seropositivity and mild to moderate COPD: clinical implications in an Asian country with a high prevalence of H. pylori.

Authors:  Ha Youn Lee; Ji Won Kim; Jung Kyu Lee; Eun Young Heo; Hee Soon Chung; Deog Keom Kim
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-08-31

7.  Helicobacter pylori is associated with weakened pulmonary function and reduced incidence of allergic conditions in patients with chronic cough.

Authors:  Meng He; Yuanyuan Zheng; A'Huo Ma; Chunyi Zhang; Yuefang Yu; Hua Wang; Yefeng Chen; Min Xiang; Kelong Tao; Juxin Shen
Journal:  Exp Ther Med       Date:  2020-09-03       Impact factor: 2.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.